The global nuclear medicine market was valued at $5.5 billion in 2023, and is projected to reach $16.1 Billion by 2033, growing at a CAGR of 11.3% from 2024 to 2033
The Asia-Pacific nuclear medicine market size was valued at $4,116.43 million in 2020, and is projected to reach $8,957.89 million by 2028, registering a CAGR of 10.4% from 2021 to 2028.
The Malaysia nuclear medicine market was valued at $33.68 million in 2020, and is projected to reach $70.24 million by 2028, registering a CAGR of 9.86% from 2021 to 2028.
